DrugPatentWatch Database Preview
Drugs in MeSH Category Immunosuppressive Agents
» See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celgene | THALOMID | thalidomide | CAPSULE;ORAL | 020785-004 | Jan 10, 2007 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-002 | Oct 11, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
Baxter Hlthcare | CYTOXAN | cyclophosphamide | TABLET;ORAL | 012141-002 | Approved Prior to Jan 1, 1982 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Glenmark Pharms Ltd | TACROLIMUS | tacrolimus | OINTMENT;TOPICAL | 210393-001 | Apr 16, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Veloxis Pharms Inc | ENVARSUS XR | tacrolimus | TABLET, EXTENDED RELEASE;ORAL | 206406-001 | Jul 10, 2015 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-001 | Oct 11, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
Veloxis Pharms Inc | ENVARSUS XR | tacrolimus | TABLET, EXTENDED RELEASE;ORAL | 206406-002 | Jul 10, 2015 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |